Effects of Ochratoxin A and Sodium Barbitate on Tumor Development in Rats
Author Information
Author(s): Peter G. Mantle, Miloslav Dobrota, Cheryl E. Gillett, Edward W. Odell, Sarah E. Pinder
Primary Institution: Imperial College London
Hypothesis
Can sodium barbitate accelerate tumorigenesis initiated by dietary ochratoxin A in rats?
Conclusion
Sodium barbitate slightly accelerated mammary tumor development in female rats but had minimal effect on renal tumorigenesis in male rats initiated by ochratoxin A.
Supporting Evidence
- Renal tumors in males given barbitate became evident after a latency of one year.
- Female mammary tumorigenesis was advanced by at least 6 months in rats given the OTA-barbitate regimen.
- Diagnosis of malignant mammary angiosarcoma in a female given the OTA-barbitate regimen is a new finding.
Takeaway
This study looked at how a toxin in food and a drug might cause tumors in rats. It found that the drug helped tumors grow faster in female rats but not much in male rats.
Methodology
Young rats were fed a diet contaminated with ochratoxin A for 36 weeks, followed by sodium barbitate treatment for life, with pathological outcomes studied at the end of their natural life.
Potential Biases
Potential bias due to the small sample size and the specific genetic background of the rats used.
Limitations
The study is a pilot and has a small sample size, limiting the generalizability of the findings.
Participant Demographics
Male and female Sprague Dawley rats, with a focus on a hybrid strain.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website